Filter
1676
Filtered Results: 1676
Text search:
registration
of
drugs
Featured
Recommendations
144
New Publications
558
Language
Document type
No document type
1151
Guidelines
189
Studies & Reports
170
Manuals
63
Strategic & Response Plan
61
Training Material
17
Situation Updates
10
Fact sheets
10
Resource Platforms
4
Brochures
1
Countries / Regions
India
162
Kenya
72
Sierra Leone
46
Uganda
45
Nigeria
44
Nepal
43
Ethiopia
41
South Africa
41
Ghana
40
Rwanda
38
Malawi
35
Tanzania
33
Liberia
32
Bangladesh
31
Western and Central Europe
31
Global
31
Myanmar / Burma
27
Zambia
24
Namibia
23
Africa
23
Ukraine
22
Botswana
19
Philippines
17
Eastern Europe
17
Latin America and the Carribbean
16
Zimbabwe
15
Syria
15
Cambodia
14
Indonesia
13
Lesotho
13
South Sudan
12
Asia
12
Mozambique
11
South–East Asia Region
11
Congo, Democratic Republic of
9
Senegal
6
Pakistan
6
Eswatini/ Swaziland
6
Colombia
6
Russia
6
Tajikistan
5
Haiti
4
Jordan
4
Lebanon
4
Sudan
4
Benin
4
East and Southern Africa
4
Eastern Europe and Central Asia
4
Albania
4
Cameroon
3
Iraq
3
Afghanistan
3
Germany
3
Brazil
3
North Macedonia
3
Sri Lanka
3
West and Central Africa
3
Venezuela
3
Moldova
3
Iran
3
Georgia
3
Burkina Faso
2
Saudi Arabia
2
Argentina
2
Greece
2
Libya
2
Angola
2
Chile
2
Middle East and North Africa
2
Bhutan
2
Palestine
2
Armenia
2
Laos
2
Turkmenistan
2
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
Somalia
1
Egypt
1
Thailand
1
Gambia
1
China
1
Malaysia
1
Ireland
1
Singapore
1
Papua New Guinea
1
Central African Republic
1
Peru
1
Ecuador
1
Bolivia
1
Madagascar
1
Yemen
1
Paraguay
1
Fiji
1
Djibouti
1
Timor Leste/ East Timor
1
Qatar
1
Bulgaria
1
Lithuania
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
North America
1
Uruguay
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
878
Clinical Guidelines
129
Public Health
71
Women & Child Health
60
Key Resources
34
Pharmacy & Technologies
28
Capacity Building
22
Toolboxes
TB
170
HIV
165
Pharmacy
74
Mental Health
71
AMR
70
COVID-19
53
Conflict
42
NTDs
34
Caregiver
33
Refugee
25
NCDs
23
Disability
22
Rapid Response
15
Global Health Education
13
Ebola
10
Natural Hazards
10
Specific Hazards
8
Planetary Health
8
Polio
4
Health Financing Toolbox
4
Cholera
3
Zika
3
Social Ethics
3
South Sudan
2
RESULTS: Between 76 and 97% of the PHCS offered RMCAH services before the lockdown. Except in antenatal, delivery and adolescent care, there was a decline of between 2 and 6% in all the services dur...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, c...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent C...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and da...
More than 700 000 people lose their life to suicide every year. A core foundation of suicide prevention is the timely registration and regular monitoring ... suicide and self-harm. Surveillance data can be used to show important progress towards reaching global targets, such as reducing the suicide rate by one third by 2030 as articulated in the UN SDGs and in the WHO Mental Health Action Plan 2013-2030. However, there are considerable discrepancies in the quality of data on suicide and self-harm globally. The aim of this training manual is to equip fieldworkers and supervisors with the skills to collect and manage data on suicide and self-harm in the community via key informants, health-care facilities and police records. In doing so, the value and overall goal is to strengthen the surveillance of suicide and self-harm in communities, particularly in LMICs and hard-to-reach communities where CRVS systems are weak or absent.
Rabies is a fatal viral zoonosis and serious public health problem.1 All mammals are believed to be susceptible to the disease, and for the purposes of this document, use of the term animal refers t...
Background
Chronic congestive heart failure is a common condition that, if untreated, markedly impairs the quality of life and is associated with a high risk of recurrent hospitalization and death....
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary ... the opportunities for – and threats to – expanding access to affordable antiretroviral therapy (ART).
The report is supplemented by 11 drug profiles that contain more detailed information on pricing trends and patent barriers for key antiretroviral drugs and fixed-dose combinations. Also included is an annex of conditions that define eligibility for reduced prices from 15 pharmaceutical companies.
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner drug ...
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasit...
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
DRUGS REGULATORY UNIT | NOVEMBER 2009 | SECOND EDITION
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Cha...
SOP explaining how to complete a stock card in order to track the number (quantity) of drugs in the stores area.
Last revised 2015.
Original Word document on:
http://www.epnetwork.org/Resource...
Global UNIDO Project: Strengthening the local production of essential generic drugs in the least developed and developing countries
The purpose of adding the books to the website of MCAI for download, is to make this life-saving, up-to-date information available to all who need it. Fill in a short ... field and you can download the pdf-files.
If you work in a hospital in a low income country - providing free care - you are probably intitled to FREE copies of these books. MCAI will send them to you, all you have to do is to read our Flyer and fill in the request form.
CHAPTER 206 | An Act to establish a national drug policy and a national drug authority to ensure the availability, at all times, of essential, efficacious and cost-effective drugs to the entire popu...
As of 21 March 2019, a total of 250,000 people are reported to be affected by the floods in nine districts. An estimated 48 per cent of the affecte...
This resource consists of technical guidelines for District Medical Officers, counselors and laboratory technicians for second-line antiretroviral therapy drugs, operational guidelines for pilot rol...
